Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
We report our long-term results of a self-injection program, in a large number of patients, at our sexual dysfunction center. The results demonstrate the efficacy of the polydrug solution of papaverine-phentolamine-prostaglandin E1 in terms of a long-term durable response with a reduction in side-effects.
Valdevenito
R
R
Department of Urology, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
Melman
A
A
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000527:Alprostadil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D004338:Drug Combinations; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D018783:Impotence, Vasculogenic / Q000188:drug therapy; D007267:Injections; D008297:Male; D008875:Middle Aged; D010208:Papaverine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D010413:Penis; D010646:Phentolamine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D011317:Priapism / Q000139:chemically induced; D012646:Self Administration / Q000009:adverse effects
D004338:Drug Combinations; D010208:Papaverine; D000527:Alprostadil; D010646:Phentolamine